Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Mirum Pharmaceuticals, Inc.MIRM · Entity 2416 | SVP, GLOBAL CONTROLLER | September 02, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Mirum Pharmaceuticals, Inc.
Report date September 02, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 616 |
Reported balance
After 2026-09-02 transaction · row 1
1 source rowRow 1 · 2026-09-02 · Sale · Disposed 658 · Balance 616 F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 18, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 06, 2025 Filed Jan 8, 2025 21:38 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-001142 · form4-01082025_090147.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023, January 6, 2024 and January 6, 2025. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023, January 6, 2024 and January 6, 2025. Read SEC document |
| January 06, 2025 Filed Jan 8, 2025 21:38 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-25-001142 · form4-01082025_090147.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,676 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 22:34 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001415889-24-026974 · form4-11152024_101149.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,900 Underlying: Common Stock · 2,500 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the 62,500 shares originally subject to the option vested one year after February 28, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 22:34 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 2,500 | $47.10 | $117,752.00 |
DisclosureSEC source: 0001415889-24-026974 · form4-11152024_101149.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,426 Read SEC document |
| November 14, 2024 Filed Nov 15, 2024 22:34 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 2,500 | $2.94 | $7,350.00 |
DisclosureSEC source: 0001415889-24-026974 · form4-11152024_101149.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,926 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 02, 2024 Filed Jul 3, 2024 22:19 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 375 | $34.00 | $12,750.00 |
DisclosureSEC source: 0001415889-24-019276 · form4-07032024_100734.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,426 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 22:19 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-019276 · form4-07032024_100734.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,041 Underlying: Common Stock · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. Read SEC document |
| July 01, 2024 Filed Jul 3, 2024 22:19 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-019276 · form4-07032024_100734.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| February 02, 2024 Filed Feb 3, 2024 02:28 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 735 | $26.19 | $19,250.97 |
DisclosureSEC source: 0001415889-24-002412 · form4-02032024_020214.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,759 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:28 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,772 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-002412 · form4-02032024_020214.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,543 Underlying: Common Stock · 1,772 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares will vest January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 31, 2024. 1,772 shares vested on January 31, 2024 ; 1,772 shares will vest January 31, 2025 and the remaining 1,771 shares will vest on January 31, 2026. Read SEC document |
| January 31, 2024 Filed Feb 3, 2024 02:28 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,772 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-002412 · form4-02032024_020214.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantRestricted Stock Units · Derivative | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-001827 · form4-01252024_070108.xml · derivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,500 Underlying: Common Stock · 4,500 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. F3 · derivative.exercise_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. F3 · derivative.expiration_date: 1/3rd of the shares subject to the restricted stock units shall vest on each anniversary of January 23, 2024 (the "Vesting Commencement Date"), such that the entire award will be vested on the three-year anniversary of the Vesting Commencement Date. Read SEC document |
| January 23, 2024 Filed Jan 26, 2024 00:10 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | GrantStock Option (right to buy) · Derivative | 18,000 | $0.00 Strike: $26.49 | $0.00 |
DisclosureSEC source: 0001415889-24-001827 · form4-01252024_070108.xml · derivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,000 Underlying: Common Stock · 18,000 shares Expires 2034-01-22 F1 · derivative.exercise_date: 1/4th of the shares vest one year after January 23, 2024 (the "Vesting Commencement Date") and the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 01:09 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 528 | $28.04 | $14,802.53 |
DisclosureSEC source: 0001415889-24-000880 · form4-01102024_010137.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 722 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| January 06, 2024 Filed Jan 10, 2024 01:09 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-000880 · form4-01102024_010137.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 Underlying: Common Stock · 1,250 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023 and January 6, 2024 and the remaining 1,250 shares will vest on January 6, 2025. F3 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning January 6, 2023. 1,250 shares vested on each of January 6, 2023 and January 6, 2024 and the remaining 1,250 shares will vest on January 6, 2025. Read SEC document |
| January 06, 2024 Filed Jan 10, 2024 01:09 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,250 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001415889-24-000880 · form4-01102024_010137.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, GLOBAL CONTROLLER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 22:16 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $2.94 | $0.00 |
DisclosureSEC source: 0001209191-23-057650 · doc4.xml · derivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,400 Underlying: Common Stock · 2,500 shares Expires 2029-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 1/4th of the 62,500 shares originally subject to the option vested one year after February 28, 2019, and the balance of the shares vest in a series of 36 successive equal monthly installments at the end of each month thereafter. Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 22:16 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 2,500 | $32.40 | $81,000.00 |
DisclosureSEC source: 0001209191-23-057650 · doc4.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| December 05, 2023 Filed Dec 6, 2023 22:16 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 2,500 | $2.94 | $7,350.00 |
DisclosureSEC source: 0001209191-23-057650 · doc4.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 20:30 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 3,459 | $26.23 | $90,743.06 |
DisclosureSEC source: 0001209191-23-047515 · doc4.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| July 03, 2023 Filed Jul 5, 2023 23:33 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | SaleCommon Stock | 915 | $25.65 | $23,466.64 |
DisclosureSEC source: 0001209191-23-041333 · doc4.xml · nonDerivative · entry 3 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,459 F2 · kind: Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:33 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionRestricted Stock Units · Derivative | 1,042 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041333 · doc4.xml · derivative · entry 5 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,083 Underlying: Common Stock · 1,042 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F4 · derivative.exercise_date: The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. F4 · derivative.expiration_date: The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023. Read SEC document |
| July 01, 2023 Filed Jul 5, 2023 23:33 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,042 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-041333 · doc4.xml · nonDerivative · entry 2 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,374 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 23:33 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionPerformance Restricted Stock Units · Derivative | 1,563 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-041333 · doc4.xml · derivative · entry 4 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,563 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). F3 · derivative.exercise_date: On March 9, 2021, the reporting person was granted performance-based restricted stock units ("PSUs"), which vest upon the satisfaction of certain performance criteria. On September 29, 2021, such performance criteria were met. 1,562 shares subject to the PSUs vested on September 29, 2021, and 1,563 shares vested on June 30, 2023. F3 · derivative.expiration_date: On March 9, 2021, the reporting person was granted performance-based restricted stock units ("PSUs"), which vest upon the satisfaction of certain performance criteria. On September 29, 2021, such performance criteria were met. 1,562 shares subject to the PSUs vested on September 29, 2021, and 1,563 shares vested on June 30, 2023. Read SEC document |
| June 30, 2023 Filed Jul 5, 2023 23:33 UTC | Mirum Pharmaceuticals, Inc. MIRM · Entity 2416 | Exercise / conversionCommon Stock | 1,563 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-041333 · doc4.xml · nonDerivative · entry 1 Howe Jolanda · CIK 0001974200 · SVP, Global Controller 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,332 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.